Chronic Smell and Flavor Loss Market
Chronic Smell and Flavor Loss Market Infographics

Chronic Smell and Flavor Loss

Olfactory dysfunction (OD) can be classified as either quantitative, involving alteration in the strength but not the quality of odors, or qualitative, in which the quality of odors is changed. Qualitative disorders, such as parosmia, often involve negatively perceived changes in smell quality. Qualitative changes are often found in combination with quantitative changes, whereas it is much less frequent to find qualitative changes alone. Regarding qualitative changes, parosmia, and phantosmia often occur together. 


Chronic Smell and Flavor Loss Epidemiology Segmentation in the 7MM


  • Total Prevalent Cases
  • Total Diagnosed Cases
  • Gender-specific Diagnosed Cases of Chronic Smell and Flavor Loss (excluding COVID-19)
  • Age-specific Diagnosed Cases of Chronic Smell and Flavor Loss (excluding COVID-19)
  • Etiology-specific Diagnosed Cases of Chronic Smell and Flavor Loss (excluding COVID-19)


Chronic Smell and Flavor Loss Epidemiological Insights Observed in the 7MM (2021)

The total number of incident cases of Chronic Smell and Flavor Loss observed in the 7MM was observed to be ~214 million in the year 2021 


Chronic Smell and Flavor Loss Market Insight

The market size of Chronic Smell and Flavor Loss in the 7MM was found to be approximately USD 3 billion in 2021


Chronic Smell and Flavor Loss Market Strengths

According to the CDC, in the US itself around 50 million adults have chronic daily pain, with around 20 million adults experiencing high impact Chronic Smell and Flavor Loss that interferes with daily life or work activities, indicating the huge opportunity in this area.


Chronic Smell and Flavor Loss Market Opportunities

The poor sensitivity of self-reported olfactory impairment suggests that for the majority of those affected, the individual suffering is not sufficient to seek treatment.


Chronic Smell and Flavor Loss Emerging Drug and Key Companies


  • CYR-064: Cyrano Therapeutics, and others